1. Home
  2. VYX vs PSNL Comparison

VYX vs PSNL Comparison

Compare VYX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.34

Market Cap

873.0M

Sector

N/A

ML Signal

HOLD

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$6.01

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
PSNL
Founded
1881
2011
Country
United States
United States
Employees
13500
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
873.0M
729.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VYX
PSNL
Price
$6.34
$6.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$14.25
$12.20
AVG Volume (30 Days)
2.2M
1.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.58
EPS
N/A
N/A
Revenue
N/A
$69,648,000.00
Revenue This Year
N/A
$15.47
Revenue Next Year
N/A
$39.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.02
$3.09
52 Week High
$14.67
$11.50

Technical Indicators

Market Signals
Indicator
VYX
PSNL
Relative Strength Index (RSI) 37.63 34.43
Support Level $6.04 $4.65
Resistance Level $7.17 $9.64
Average True Range (ATR) 0.29 0.50
MACD 0.11 -0.04
Stochastic Oscillator 42.86 8.06

Price Performance

Historical Comparison
VYX
PSNL

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: